This federal contract award, valued at $3,587.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026.
The contract covers the supply of Quillivant XR 25 mg/5 ml suspension, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). This contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible for delivering the pharmaceutical product to support the healthcare needs of military personnel, veterans, and other federal beneficiaries through the DLA's comprehensive contracting mechanism.
Generated 3/27/25, 9:45 AM